- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cutia Therapeutics (2487)
Cutia Therapeutics stock price live, this page displays HK 2487 stock exchange data. View the 2487 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cutia Therapeutics real time stock price chart below.
What Is the Cutia Therapeutics Stock Price Today?
The Cutia Therapeutics stock price today is 8.80.
What Is the Stock Symbol for Cutia Therapeutics?
The stock symbol for Cutia Therapeutics is ""2487.""
What Stock Exchange Does Cutia Therapeutics Trade On?
Cutia Therapeutics is listed and trades on the Hong Kong stock exchange.
Is Cutia Therapeutics a Good Stock to Buy?
Determining whether Cutia Therapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2487 quote. (ISIN: KYG2606C1006)
What Is the Cutia Therapeutics Stock Price Today?
The Cutia Therapeutics stock price today is 8.80.
What Is the Stock Symbol for Cutia Therapeutics?
The stock symbol for Cutia Therapeutics is ""2487.""
What Stock Exchange Does Cutia Therapeutics Trade On?
Cutia Therapeutics is listed and trades on the Hong Kong stock exchange.
Is Cutia Therapeutics a Good Stock to Buy?
Determining whether Cutia Therapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2487 quote. (ISIN: KYG2606C1006)
Hong Kong
Currency in HKD
8.80
+0.25(+2.92%)
Delayed Data·
Fair Value
An estimate of a Cutia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.47
9.48
52 wk Range
3.64
18.26
2487 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
2487 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cutia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.479.48
52 wk Range
3.6418.26
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2487 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cutia Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
10.88
Upside
+23.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Cutia Therapeutics Company Profile
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong. It focuses on the dermatology treatment and care therapeutic areas, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management medication. The company’s products include CU-40102, a topical finasteride spray approved for androgenetic alopecia treatment; CU-10201, a topical 4% minocycline foam, for acne vulgaris treatment; and CU-10101, a topical novel small molecule agent, and a non-hormonal and small molecule drug, which is in Phase I, for the treatment of mild to moderate atopic dermatitis. It is also involved in the development of CU-20401, a recombinant mutant collagenase, currently under Phase II clinical trial for submental adipose accumulation (submental fat); CU-40101, a topical small molecule thyroid hormone receptor agonist liniment, currently completed Phase I clinical trial for the treatment of androgenetic alopecia; and CU-30101, a localized topical lidocaine and tetracaine compound topical anesthesia cream, completed Phase III clinical trial for surface dermatologic operations. In addition, the company provides CATAME, a technology platform that enables the development of a wide range of product dosage forms and the relevant formulation technology. Further, it offers product pipeline of creams, sprays, ointments, aerosol foams and other dosage forms through the CATAME platform. The company was incorporated in 2019 and is headquartered in Shanghai, China.
Compare 2487 to Peers and Sector
Metrics to compare | 2487 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2487PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.7x | −16.0x | −0.5x | |
PEG Ratio | −0.07 | 0.15 | 0.00 | |
Price/Book | 2.6x | 4.9x | 2.6x | |
Price / LTM Sales | 8.9x | 12.3x | 3.3x | |
Upside (Analyst Target) | 11.1% | −1.1% | 43.3% | |
Fair Value Upside | Unlock | −14.4% | 6.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.88
(+23.59% Upside)
Earnings
Latest Release
Apr 22, 2025
EPS / Forecast
-0.75 / --
Revenue / Forecast
184.04M / --
FAQ
What Stock Exchange Does Cutia Therapeutics Trade On?
Cutia Therapeutics is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Cutia Therapeutics?
The stock symbol for Cutia Therapeutics is "2487."
What Is the Cutia Therapeutics Market Cap?
As of today, Cutia Therapeutics market cap is 2.72B.
What Is Cutia Therapeutics's Earnings Per Share (TTM)?
The Cutia Therapeutics EPS (TTM) is -1.41.
From a Technical Analysis Perspective, Is 2487 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Cutia Therapeutics Stock Split?
Cutia Therapeutics has split 0 times.
How Many Employees Does Cutia Therapeutics Have?
Cutia Therapeutics has 333 employees.
What is the current trading status of Cutia Therapeutics (2487)?
As of 11 Aug 2025, Cutia Therapeutics (2487) is trading at a price of 8.80, with a previous close of 8.55. The stock has fluctuated within a day range of 8.47 to 9.48, while its 52-week range spans from 3.64 to 18.26.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.